Subject: RE: Oversight Committee Call
From: "Averhoff, Francisco (CDC/OID/NCHHSTP)" <[email-masked]>
To: Angela Macedo; Graeme Robertson
Cc: Diana Brainard; Ruth Diazaraque-Marin; Christina Carlson; Ward, John (CDC/OID/NCHHSTP); David Sergeenko; Valeri (Georgia); valeri; Nasrullah, Muazzam (CDC/OID/NCHHSTP); Morgan, Juliette (CDC/CGH/DGHP); Glass, Nancy (CDC/OID/NCHHSTP) (CTR); Koscelski, Anna (CDC/OID/NCHHSTP) (CTR)
Date: Wed, 29 Jun 2016 16:58:55 +0000

Dear all,

I have NOT seen the meeting invite yet?

I will be cc ask Anna, to send invite to all on this e-mail with a call-in number for meeting:

Meeting Title:  Georgia Oversight Committee

Date: 30 June 2016

Time: 8 AM Pacific/11 AM EDT (Atlanta)/7PM Tbilisi

Look forward to our meeting, tmrw.

Best, FA

Francisco Averhoff MD, MPH

CAPT US Public Health Service

Associate Director for Global Health

Division of Viral Hepatitis

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Centers for Disease Control and Prevention

1600 Clifton Road, MS G-37

Atlanta, GA 30333

phone: 404-718-8501

fax: 404-718-8588

e-mail: [email-masked]

From: Angela Macedo [mailto:[email-masked]]

Sent: Tuesday, June 21, 2016 8:12 PM

To: Averhoff, Francisco (CDC/OID/NCHHSTP) <[email-masked]>; Graeme Robertson <[email-masked]>

Cc: Diana Brainard <[email-masked]>; Ruth Diazaraque-Marin <[email-masked]>; Christina Carlson <[email-masked]>; Ward, John (CDC/OID/NCHHSTP) <[email-masked]>; Davit Sergeenko <[email-masked]>; Valeri (Georgia)
<[email-masked]>; valeri <[email-masked]>

Subject: RE: Oversight Committee Call

Wonderful, I’ll send the meeting invite out immediately.

Thank you for your help!

Cheers,

Angela

Angela Macedo | Executive Assistant to Gregg Alton, Executive Vice President,
Commercial and Access Operations ALA, Corporate and Medical Affairs| Gilead Sciences, Inc. | 333 Lakeside Drive | Foster City, CA 94404 | Phone: +1 650.522.6232 | Fax: +1 650.577.6736 | e-mail:
[email-masked]

From: Averhoff, Francisco (CDC/OID/NCHHSTP) [mailto:[email-masked]]

Sent: Tuesday, June 21, 2016 4:42 PM

To: Graeme Robertson; Angela Macedo

Cc: Diana Brainard; Ruth Diazaraque-Marin; Christina Carlson; Ward, John (CDC/OID/NCHHSTP); Davit Sergeenko; Valeri (Georgia); valeri

Subject: RE: Oversight Committee Call

We would like to confirm that 30 June works (27 June does not).

Will look for invite from Angela, and will forward to others as observers (2 or 3 from CDC).

Thank you, FA

From: Graeme Robertson [mailto:[email-masked]]

Sent: Tuesday, June 21, 2016 10:52 AM

To: Angela Macedo <[email-masked]>; Averhoff, Francisco (CDC/OID/NCHHSTP) <[email-masked]>

Cc: Diana Brainard <[email-masked]>; Ruth Diazaraque-Marin <[email-masked]>; Christina Carlson <[email-masked]>;
Ward, John (CDC/OID/NCHHSTP) <[email-masked]>; Davit Sergeenko <[email-masked]>; Valeri (Georgia) <[email-masked]>;
valeri <[email-masked]>

Subject: RE: Oversight Committee Call

Dear Ange,

Monday works for me too.

Best wishes

Graeme

Graeme.A Robertson

Senior Director,  Africa & CIS

Access Operations & Emerging Markets

--------------------------------------------------------------------------------------------------------------------------------------------------

Gilead Sciences Europe Ltd
• Registered as a limited company in England and Wales • Registered number
05510315

Registered office:
South Building • 2 Roundwood Avenue • Stockley Park • Uxbridge • UB11 1AZ • England

Telephone:
+44(0)208 587 2228
• Mobile: +44(0)7789 268 043 • Fax:
+44(0)208 744 6773

From: Angela Macedo

Sent: 21 June 2016 15:00

To: Averhoff, Francisco (CDC/OID/NCHHSTP)

Cc: Diana Brainard; Ruth Diazaraque-Marin; Graeme Robertson; Christina Carlson; Ward, John (CDC/OID/NCHHSTP); Davit Sergeenko; Valeri (Georgia); valeri

Subject: Re: Oversight Committee Call

Greetings,

Thank you for your reply. Dr. Sergeenko has confirmed either date will work for him. I will wait to hear from Dr. Ward before proceeding with an invite to include a dial-in.

Sincerely,

Angela

Sent from my iPad

On Jun 21, 2016, at 2:39 AM, Averhoff, Francisco (CDC/OID/NCHHSTP) <[email-masked]> wrote:

Resending plus adding another e-mail for Dr. Sergeenko (he bounced back on my previous e-mail), and adding Dr. Valeri.

Best, FA

Sent from my BlackBerry 10 smartphone on the Verizon Wireless 4G LTE network.

From:
Averhoff, Francisco (CDC/OID/NCHHSTP)

Sent:
Tuesday, June 21, 2016 15:23

To:
Angela Macedo; Davit Sergeenko (); Diana Brainard

Cc:
Ruth Diazaraque-Marin; Graeme Robertson; Christina Carlson; Ward, John (CDC/OID/NCHHSTP)

Subject:
Re: Oversight Committee Call

Angela- thank you for working with us, I believe it will be Dr. Ward and me for CDC, and I think the 30th will work for ‎us (27 not good), but need to confirm
with Dr. Ward‎. We will revert shortly.

And of course Dr. Sergeenko‎ must be amenable, with the time/date.

Best, FA

Sent from my BlackBerry 10 smartphone on the Verizon Wireless 4G LTE network.

From:
Angela Macedo

Sent:
Tuesday, June 21, 2016 03:08

To:
Averhoff, Francisco (CDC/OID/NCHHSTP); Davit Sergeenko (); Diana Brainard

Cc:
Ruth Diazaraque-Marin; Graeme Robertson; Christina Carlson

Subject:
Oversight Committee Call

Greetings,

Gregg Alton has requested I set up a 2 hour Oversight Committee Call.  We reviewed the calendar and have identified these two dates as possibilities:

Monday, June 27th 8:00am Pacific/6:00pm Ukraine

Thursday, June 30th 8:00am Pacific/6:00pm Ukraine

If you would kindly let me know if either of these dates will work.  Gregg’s travel schedule is very busy over the next couple of months, so we were hoping to take advantage
of one of these dates, but we are happy to look for additional dates if neither date is convenient.

Francisco and Davit, we understand there may be an additional attendees in addition to yourselves on this call, if you would please confirm if there will be others on
the call, I’m happy to include them on the invite.

Sincerely,

Angela

Angela Macedo | Executive Assistant to Gregg Alton,
Executive Vice President, Commercial and Access Operations ALA, Corporate and Medical Affairs|
Gilead Sciences, Inc. | 333 Lakeside Drive | Foster City, CA 94404 | Phone: +1 650.522.6232 | Fax: +1 650.577.6736 | e-mail:
[email-masked]

DISCLAIMER If you have received this message in error, please contact the sender immediately by return e-mail and notify the sender and then delete this message
(including any attachments) from your system. This communication and any attachments contain information which is confidential and may also be legally privileged. It is for the exclusive use of the intended recipient(s). If you are not the intended recipient(s)
please note that any form of disclosure, distribution, copying or use of this communication or the information in it or in any attachments is strictly prohibited and may be unlawful. E-mail communications cannot be guaranteed to be secure or error free, as
information could be intercepted, corrupted, amended, lost, destroyed, arrive late or incomplete, or contain viruses. Gilead does not accept liability for any such matters or their consequences. Anyone who communicates with Gilead by e-mail is taken to accept
the risks in doing so. Gilead has taken every reasonable precaution to ensure that any attachment to this e-mail has been swept for viruses. However, Gilead cannot accept liability for any damage sustained as a result of viruses and would advise that you carry
out your own virus checks before opening any attachment. Gilead Sciences Europe Ltd ; Registered as a limited company in England and Wales ; Registered number 5510315 Registered office: South Building ; 2 Roundwood Avenue ; Stockley Park ; Uxbridge ; UB11
1AF ; England